Intrathecal gadolinium-based contrast agents (off-label)
Publisher
Radiopaedia.org
Reference5 articles.
1. Patel M, Atyani A, Salameh J, McInnes M, Chakraborty S. Safety of Intrathecal Administration of Gadolinium-Based Contrast Agents: A Systematic Review and Meta-Analysis. Radiology. 2020;297(1):75-83.
2. Nacar Dogan S, Kizilkilic O, Kocak B, Isler C, Islak C, Kocer N. Intrathecal Gadolinium-Enhanced MR Cisternography in Patients with Otorhinorrhea: 10-Year Experience of a Tertiary Referral Center. Neuroradiology. 2018;60(5):471-7.
3. Albes G, Weng H, Horvath D, Musahl C, Bäzner H, Henkes H. Detection and Treatment of Spinal CSF Leaks in Idiopathic Intracranial Hypotension. Neuroradiology. 2012;54(12):1367-73.
4. Calvo N, Jamil M, Feldman S, Shah A, Nauman F, Ferrara J. Neurotoxicity from Intrathecal Gadolinium Administration. Neur Clin Pract. 2020;10(1):e7-e10.
5. Kanal E. A Reality Check on Intrathecal Gadolinium-Based Contrast Agents. Radiology. 2020;297(1):84-6.